Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Randomized, No-treatment Controlled, Evaluator-blinded, Superiority Clinical Trial to Evaluate the Efficacy and Safety of LANLUMA V to Improve Jawline Contour Deficit

NCT06391580 is registered in ClinicalTrials.gov with Sinclair Pharmaceuticals Limited as lead sponsor.

NCT NCT06391580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06391580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Randomized, No-treatment Controlled, Evaluator-blinded, Superiority Clinical Trial to Evaluate the Efficacy and Safety of LANLUMA V to Improve Jawline Contour Deficit
Lead sponsor
Sinclair Pharmaceuticals Limited
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2024
Completion date
April 30, 2025
Enrollment
192 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

jawline contour deficit